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Résumé en
anglais
Acute intermittent porphyria (AIP), an inherited hepatic disorder, is due to a defect
of hydroxymethylbilane synthase (HMBS), an enzyme involved in heme biosynthesis.
AIP is characterized by recurrent, life-threatening attacks at least partly due to the
increased hepatic production of 5-aminolaevulinic acid (ALA). Both the mitochondrial
enzyme, ALA synthase (ALAS) 1, involved in the first step of heme biosynthesis,
which is closely linked to mitochondrial bioenergetic pathways, and the promise of
an ALAS1 siRNA hepatic therapy in humans, led us to investigate hepatic energetic
metabolism in Hmbs KO mice treated with phenobarbital. The mitochondrial
respiratory chain (RC) and the tricarboxylic acid (TCA) cycle were explored in the
Hmbs−/− mouse model. RC and TCA cycle were significantly affected in comparison
to controls in mice treated with phenobarbital with decreased activities of RC
complexes I (−52%, **p < 0.01), II (−50%, **p < 0.01) and III (−55%, *p < 0.05),
and decreased activity of α-ketoglutarate dehydrogenase (−64%, *p < 0.05), citrate
synthase (−48%, **p < 0.01) and succinate dehydrogenase (−53%, *p < 0.05).
Complex II-driven succinate respiration was also significantly affected. Most of these
metabolic alterations were at least partially restored after the phenobarbital arrest
and heme arginate administration. These results suggest a cataplerosis of the TCA
cycle induced by phenobarbital, caused by the massive withdrawal of succinyl-CoA
by ALAS induction, such that the TCA cycle is unable to supply the reduced cofactors
to the RC. This profound and reversible impact of AIP on mitochondrial energetic
metabolism offers new insights into the beneficial effect of heme, glucose and ALAS1
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